Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online February 17, 2009.
Article Versions
- You are currently viewing a Latest version of this article (February 17, 2009 - 12:45).
- View the most recent version of this article
Copyright & Usage
© 2009 The Journal of Rheumatology
Author Information
- Edward Keystone,
- Bruce Freundlich,
- Michael Schiff,
- Juan Li and
- Michele Hooper
- From Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada; Wyeth Research, Collegeville, Pennsylvania; University of Colorado, Denver, Colorado; and Amgen Inc., Thousand Oaks, California, USA.
Supported by Immunex Corporation, a wholly owned subsidiary of Amgen Inc., and by Wyeth Research.
E. Keystone has conducted research, served on consultant/advisory boards, and/or participated as a speaker for Abbott Laboratories, Amgen, Aventis Pharma, Bristol-Myers Squibb, Celltech, Centocor, CombinatoRx, Genentech, Hoffman-La Roche Ltd (Canada), Novartis, Schering Plough, Targeted Genetics, Therakos, and Wyeth Research. M. Schiff has conducted research, served as a consultant, and/or participated as a speaker for Abbott Laboratories, Amgen, Bristol-Myers Squibb, Centocor, Genentech, Roche, UCB, Targeted Therapies, and Wyeth Research. B. Freundlich is an employee of Wyeth Research. M. Hooper and J. Li are employees of Amgen.
E. Keystone, MD, FRCPC, Mount Sinai Hospital, University of Toronto, Toronto, ON; B. Freundlich, MD, Wyeth Research, Collegeville, PA; M. Schiff, MD, University of Colorado, Denver, CO; J. Li, PhD; M. Hooper, MD, Amgen Inc., Thousand Oaks, CA. Address reprint requests to Dr. E. Keystone, Mount Sinai Hospital, The Rebecca MacDonald Centre for Arthritis and Autoimmunity, 60 Murray St., Room 2-006, Toronto, ON M5G 1X5, Canada. E-mail: edkeystone@mtsinai.on.ca
Accepted for publication October 31, 2008.